BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The International Society for Vaccines - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The International Society for Vaccines
X-ORIGINAL-URL:https://isv-online.org
X-WR-CALDESC:Events for The International Society for Vaccines
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250122T000000
DTEND;TZID=UTC:20250122T235900
DTSTAMP:20260918T190942Z
CREATED:20260918T190749Z
LAST-MODIFIED:20260918T190942Z
UID:9534-1737504000-1737590340@isv-online.org
SUMMARY:Development of Nirsevimab: A Monoclonal Antibody for the Prevention of RSV Disease in Infants
DESCRIPTION:Date: Tuesday\, January 22nd \nLocation: Icahn School of Medicine at Mt. Sinai \nPresenter: Tonya Villefana\, AstraZeneca \nTitle: Development of Nirsevimab: A Monoclonal Antibody for the Prevention of RSV Disease in Infants \nRecording:  Available here.
URL:https://isv-online.org/event/development-of-nirsevimab-a-monoclonal-antibody-for-the-prevention-of-rsv-disease-in-infants/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/January-2025-Webinar-1.jpg
END:VEVENT
END:VCALENDAR